Symbol="KRYS"
AssetType="Common Stock"
Name="Krystal Biotech Inc"
Description="Krystal Biotech, Inc., a clinical-stage biotechnology company, is dedicated to the field of redosable gene therapy to treat serious rare diseases in the United States. The company is headquartered in Pittsburgh, Pennsylvania."
CIK="1711279"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="3204323000"
EBITDA="-127884000"
PERatio="None"
PEGRatio="None"
BookValue="18.98"
DividendPerShare="0"
DividendYield="0"
EPS="-5.2"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.143"
ReturnOnEquityTTM="-0.261"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-5.2"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="137.43"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="3.382"
EVToRevenue="-"
EVToEBITDA="-11.46"
Beta="0.81"
num_52WeekHigh="131.8"
num_52WeekLow="61.11"
num_50DayMovingAverage="122.48"
num_200DayMovingAverage="90.22"
SharesOutstanding="25799700"
DividendDate="None"
ExDividendDate="None"
symbol="KRYS"
open="124.35"
high="127.08"
low="123.90"
price="124.20"
volume="136287.00"
latest_trading_day="2023-08-04"
previous_close="124.58"
change="-0.38"
change_percent="-0.3050%"
aroon_positive_momentum_days="94"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="94"
Volume_recent_avg="268511"
Change_recent_avg="0.48"
Delta_recent_avg="4.06"
Variance_recent_avg="2.03"
Change_ratio_recent_avg="0.45"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="94"
Aroon_momentum_negative="6"
image_negative_thumbnail_id_1="1116"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0149.jpeg"
image_negative_thumbnail_id_2="495"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0110.jpeg"
image_neutral_thumbnail_id_1="583"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0016.jpeg"
image_neutral_thumbnail_id_2="569"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0030.jpeg"
image_positive_thumbnail_id_1="615"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0093.jpeg"
image_positive_thumbnail_id_2="1005"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0167.jpeg"
image_professor_thumbnail_id_1="1181"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0015.jpeg"
image_professor_thumbnail_id_2="1193"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
